ApprovalTrail

Approval · Notice of Compliance 1545 · 2000

TONOCARD: Notice of Compliance 1545

Issued April 26, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1545
Date
April 26, 2000
Company
Astrazeneca Canada IncMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antiarrhythmic agent

Products in this notice

BrandDINStatus today
TONOCARD00598941Cancelled Post Market

Medicinal ingredients